Alvan Feinstein

Q: What Schools Are Affiliated With Alvan Feinstein

Alvan Feinstein is affiliated with the following schools: Yale University, University of Chicago, University of Pennsylvania

Alvan Feinstein's AcademicInfluence.com Rankings

Alvan Feinstein

Medical

#53

World Rank

#91

Historical Rank

#26

USA Rank

Epidemiology

#12

World Rank

#14

Historical Rank

USA Rank

medical Degrees

Alvan Feinstein

Philosophy

#1448

World Rank

#2632

Historical Rank

#585

USA Rank

Logic

#207

World Rank

#450

Historical Rank

#93

USA Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Alvan Feinstein's Degrees

Doctorate Medicine University of Pennsylvania

Why Is Alvan Feinstein Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Alvan R. Feinstein was an American clinician, researcher and an epidemiologist who made significant impact on clinical investigation, especially on the field of clinical epidemiology that he helped define. He is regarded as one of the fathers of modern clinical epidemiology. He died at the age of 75 in Toronto on 25 October 2001 and is survived by his wife and two children.

(See a Problem?)

Alvan Feinstein's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A simulation study of the number of events per variable in logistic regression analysis. (1996) (6358)
High agreement but low kappa: I. The problems of two paradoxes. (1990) (2579)
A critical appraisal of the quality of quality-of-life measurements. (1994) (2224)
Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. (1978) (1703)
High agreement but low kappa: II. Resolving the paradoxes. (1990) (1654)
Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. (1995) (1618)
The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. (1985) (1493)
THE PRE-THERAPEUTIC CLASSIFICATION OF CO-MORBIDITY IN CHRONIC DISEASE. (1970) (1344)
The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. (1984) (1260)
The Risk of Determining Risk with Multivariable Models (1993) (1096)
Clinical biostatistics: LIV. The biostatistics of concordance (1981) (1093)
Clinical Epidemiology: The Architecture of Clinical Research (1985) (804)
Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. (2002) (790)
Use of methodological standards in diagnostic test research. Getting better but still not good. (1995) (736)
The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. (1974) (660)
Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy. (1995) (655)
Problems in the "evidence" of "evidence-based medicine". (1997) (611)
Variability in radiologists' interpretations of mammograms. (1994) (596)
An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. (1979) (486)
Scientific and clinical problems in indexes of functional disability. (1986) (415)
Principles of Medical Statistics (2001) (405)
A simple procedure for general screening for functional disability in elderly patients. (1990) (393)
POST-MENOPAUSAL ŒSTROGENS PROTECT AGAINST FRACTURES OF HIP AND DISTAL RADIUS A Case-control Study (1979) (389)
THE BIOSTATISTICS OF CONCORDANCE (1981) (323)
Meta-analysis: statistical alchemy for the 21st century. (1995) (316)
Scientific standards in epidemiologic studies of the menace of daily life. (1988) (286)
Spectrum bias in the evaluation of diagnostic tests: lessons from the rapid dipstick test for urinary tract infection. (1992) (282)
An additional basic science for clinical medicine: II. The limitations of randomized trials. (1983) (270)
An additional basic science for clinical medicine: IV. The development of clinimetrics. (1983) (269)
XXXI. On the sensitivity, specificity, and discrimination of diagnostic tests (1975) (266)
On white-coat effects and the electronic monitoring of compliance. (1990) (248)
The impact of ethnicity, family income, and parental education on children's health and use of health services. (1999) (246)
Clinical symptoms and comorbidity: significance for the prognostic classification of cancer (1996) (233)
Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status. (1979) (233)
Risk for systemic embolization of atrial fibrillation without mitral stenosis. (1990) (217)
Multivariable Analysis: An Introduction (1996) (215)
The problem of "protopathic bias" in case-control studies. (1980) (211)
A comparative contrast of clinimetric and psychometric methods for constructing indexes and rating scales. (1992) (209)
Clinical Judgment Revisited: The Distraction of Quantitative Models (1994) (204)
The 'chagrin factor' and qualitative decision analysis. (1985) (202)
Alternative Analytic Methods for Case-Control Studies of Estrogens and Endometrial Cancer (1978) (194)
Methodologic problems of exercise testing for coronary artery disease: groups, analysis and bias. (1980) (191)
Clinical epidemiological quality in molecular genetic research: the need for methodological standards. (1999) (190)
Context bias. A problem in diagnostic radiology. (1996) (184)
Re: "Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.)". (1995) (184)
Indexes and boundaries for "quantitative significance" in statistical decisions. (1990) (181)
Ask patients what they want. Evaluation of individual complaints before total hip replacement. (1994) (177)
Claims of Equivalence in Medical Research: Are They Supported by the Evidence? (2000) (173)
A controlled evaluation of the risk of bacterial endocarditis in persons with mitral-valve prolapse. (1982) (164)
Problems of comorbidity in mortality after prostatectomy. (1992) (159)
Comparison of three rating scales for measuring subjective phenomena in clinical research. I. Use of experimentally controlled auditory stimuli. (2004) (158)
Clinical biostatistics (1974) (158)
The BCG controversy. A methodological and statistical reappraisal. (1983) (154)
Double standards, scientific methods, and epidemiologic research. (1982) (150)
A Clinical‐Severity Staging System for Patients with Lung Cancer (1990) (147)
Coding ordinal independent variables in multiple regression analyses. (1987) (138)
A critique of methodology in studies of anticoagulant therapy for acute myocardial infarction. (1969) (136)
New Clinical Severity Staging System for Cancer of the Larynx (1994) (136)
XXXIX. The haze of Bayes, the aerial palaces of decision analysis, and the computerized Ouija board (1977) (135)
A new prognostic staging system for the acquired immunodeficiency syndrome. (1989) (130)
Academic calculations versus clinical judgments: practicing physicians' use of quantitative measures of test accuracy. (1998) (130)
How to evaluate a diagnostic marker test. Lessons from the rise and fall of dexamethasone suppression test. (1988) (128)
Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure. (1989) (128)
A controlled study of three methods of prophylaxis against streptococcal infection in a population of rheumatic children. II. Results of the first three years of the study, including methods for evaluating the maintenance of oral prophylaxis. (1959) (125)
T. Duckett Jones Memorial Lecture. The Jones criteria and the challenges of clinimetrics. (1982) (124)
An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity. (1979) (123)
Complications of peripheral arteriography: a new system to identify patients at increased risk. (1995) (123)
Misguided efforts and future challenges for research on “diagnostic tests” (2002) (122)
Measurement of lower limb alignment using long radiographs. (1991) (122)
The 'epidemiologic necropsy'. Unexpected detections, demographic selections, and changing rates of lung cancer. (1987) (120)
Anticoagulants and myocardial infarction. The problems of pooling, drowning, and floating. (1979) (119)
Improving the reliability of orthopaedic measurements. (1992) (117)
The case-control study: valid selection of subjects. (1985) (115)
XXXIV. The other side of ‘statistical significance’: alpha, beta. delta, and the calculation of sample size (1975) (114)
Confirmations and surprises in the association of tobacco use with sinusitis. (2000) (114)
Rheumatic Fever in Children and Adolescents: A Long-term Epidemiologic Study of Subsequent Prophylaxis, Streptococcal Infections, and Clinical Sequelae: III. Comparative Effectiveness of Three Prophylaxis Regimens in Preventing Streptococcal Infections and Rheumatic Recurrences (1964) (110)
Symptoms as an Index of Biological Behaviour and Prognosis in Human Cancer (1966) (104)
The Theory and Evaluation of Sensibility (1987) (100)
New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association. (1989) (100)
Methodologic standards and contradictory results in case-control research (1979) (100)
An additional basic science for clinical medicine: I. The constraining fundamental paradigms. (1983) (98)
P-values and confidence intervals: two sides of the same unsatisfactory coin. (1998) (97)
A bibliography of publications on observer variability. (1985) (97)
Further specification and evaluation of a new clinical index for dyspnea. (1986) (95)
Clinical biostatistics; xx. The epidemiologic trohoc, the ablative risk ratio, and ‘retrospective’ research (1973) (95)
Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study. (1979) (93)
Quality-of-life measurements: origin and pathogenesis. (2002) (92)
Current problems and future challenges in randomized clinical trials. (1984) (92)
The problem of cogent subgroups: a clinicostatistical tragedy. (1998) (90)
The unit fragility index: an additional appraisal of "statistical significance" for a contrast of two proportions. (1990) (87)
The impact of clinical history on mammographic interpretations. (1997) (87)
A collection of 56 topics with contradictory results in case-control research. (1988) (87)
NECROPSY DIAGNOSIS OF ENDOMETRIAL CANCER AND DETECTION-BIAS IN CASE/CONTROL STUDIES (1981) (86)
A new staging system for cancer, and a re-appraisal of "early" treatment and "cure" by radical surgery. (1968) (86)
An analysis of Berkson's bias in case-control studies. (1986) (85)
Epidemiologic analyses of causation: the unlearned scientific lessons of randomized trials. (1989) (84)
XVI. The process of prognostic stratification (Part 2) (1972) (84)
A controlled study of three methods of prophylaxis against streptococcal infection in a population of rheumatic children. I. Streptococcal infections and recurrences of acute rheumatic fever in the first two years of the study. (1957) (83)
The inadequacy of binary models for the clinical reality of three-zone diagnostic decisions. (1990) (81)
The epidemiology of cancer therapy. IV. The extraction of data from medical records. (1969) (80)
Clinical Epidemiology: II. The Identification Rates of Disease (1968) (79)
The limited spectrum of patients studied in exercise test research. Analyzing the tip of the iceberg. (1982) (78)
Monte Carlo methods in clinical research: applications in multivariable analysis. (1997) (77)
The role of observational studies in the evaluation of therapy. (1984) (77)
The problems of the "problem-oriented medical record". (1973) (76)
SYMPTOMATIC PATTERNS, BIOLOGIC BEHAVIOR, AND PROGNOSIS IN CANCER OF THE LUNG. PRACTICAL APPLICATION OF BOOLEAN ALGEBRA AND CLINICAL TAXONOMY. (1964) (76)
THE CLINICAL PATTERNS OF ACUTE RHEUMATIC FEVER: A REAPPRAISAL (1993) (75)
Methodologic standards and contradictory results in case-control research. (1979) (75)
Asking patients what they like: overlooked attributes of patient satisfaction with primary care. (1997) (73)
Lung cancer: perspectives and prospects. (1970) (73)
An additional basic science for clinical medicine: III. The challenges of comparison and measurement. (1983) (73)
The measurment of success in weight reduction. An analysis of methods and new index. (1959) (72)
Clinimetric perspectives. (1987) (72)
XXV. A survey of the statistical procedures in general medical journals (1974) (72)
RHEUMATIC FEVER IN CHILDREN AND ADOLESCENTS. A LONG-TERM EPIDEMIOLOGIC STUDY OF SUBSEQUENT PROPHYLAXIS, STREPTOCOCCAL INFECTIONS, AND CLINICAL SEQUELAE. VII. CARDIAC CHANGES AND SEQUELAE. (1964) (72)
Clinical features of lung cancers discovered as a postmortem "surprise". (1986) (71)
Multi-item "instruments" vs Virginia Apgar's principles of clinimetrics. (1999) (69)
ICD, POR, and DRG. Unsolved scientific problems in the nosology of clinical medicine. (1988) (68)
Cancer of the larynx: a new staging system and a re-appraisal of prognosis and treatment. (1977) (68)
The epidemiology of cancer therapy. 3. The management of imperfect data. (1969) (68)
XIV. The purposes of prognostic stratification (1972) (66)
THE PROGNOSIS OF ACUTE RHEUMATIC FEVER. (1964) (66)
Comorbid and clinical determinants of prognosis in endometrial cancer. (1984) (64)
Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS). (1997) (63)
The treatment of obesity: an analysis of methods, results, and factors which influence success. (1960) (62)
Coffee and pancreatic cancer. The problems of etiologic science and epidemiologic case-control research. (1981) (62)
Improved observational method for studying therapeutic efficacy. Suggestive evidence that lidocaine prophylaxis prevents death in acute myocardial infarction. (1981) (62)
"Benign" tumors and "early detection" in mammography-screened patients of a natural cohort with breast cancer. (2000) (61)
A bibliography of publications on observer variability (final installment). (1992) (61)
Alternative analytic methods for case-control studies of estrogens and endometrial cancer. (1979) (60)
Clinical biostatistics‐VIII; An analytic appraisal of the University Group Diabetes Program (UGDP) study (1971) (59)
Relationship between nonphenacetin combined analgesics and nephropathy: a review. Ad Hoc Committee of the International Study Group on Analgesics and Nephropathy. (2000) (59)
Effect of gestational and passive smoke exposure on ear infections in children. (2002) (59)
The auxometric dimension. A new method for using rate of growth in prognostic staging of breast cancer. (1974) (58)
The role of tonsils in predisposing to streptococcal infections and recurrences of rheumatic fever. (1970) (58)
The qualification period. (1991) (58)
A Critical Overview of Diagnosis in Psychiatry (1977) (58)
An algorithm for the operational assessment of adverse drug reactions. III. Results of tests among clinicians. (1979) (56)
A comparison of multivariable mathematical methods for predicting survival--III. Accuracy of predictions in generating and challenge sets. (1990) (55)
Mimetic features of rheumatic-fever recurrences. (1960) (54)
Benefits and obstacles for development of health status assessment measures in clinical settings. (1992) (53)
A reappraisal of staging and therapy for patients with cancer of the rectum. I. Development of two new systems of staging. (1975) (50)
The steroid-croup controversy: an analytic review of methodologic problems. (1980) (50)
Estrogens and endometrial cancer. Responses to arguments and current status of an epidemiologic controversy. (1986) (50)
The need for humanised science in evaluating medication. (1972) (49)
Methodologic problems and standards in case-control research. (1979) (49)
A reappraisal of histopathology in lung cancer and correlation of cell types with antecedent cigarette smoking. (1973) (49)
A Critique of Methods in Reported Studies of Long-term Vascular Complications in Patients with Diabetes Mellitus (1973) (49)
BOOLEAN ALGEBRA AND CLINICAL TAXONOMY. I. ANALYTIC SYNTHESIS OF THE GENERAL SPECTRUM OF A HUMAN DISEASE. (1963) (49)
A new clinical-anatomic staging system for evaluating prognosis and treatment of prostatic cancer. (1986) (48)
More lung cancer but better survival. Implications of secular trends in "necropsy surprise" rates. (1989) (48)
Clinical epidemiology. I. The populational experiments of nature and of man in human illness. (1968) (47)
The epidemiology of cancer therapy. II. The clinical course: data, decisions, and temporal demarcations. (1969) (45)
Fraud, distortion, delusion, and consensus: the problems of human and natural deception in epidemiologic science. (1988) (45)
Do caffeine‐containing analgesics promote dependence? A review and evaluation (2000) (45)
A new instrument for patients’ ratings of physician performance in the hospital setting (2007) (45)
A comparison of multivariable mathematical methods for predicting survival--II. Statistical selection of prognostic variables. (1990) (45)
Operational criteria for adverse drug reactions in evaluating suspected toxicity of a popular scabicide (1980) (44)
RHEUMATIC FEVER IN CHILDREN AND ADOLESCENTS. A LONG-TERM EPIDEMIOLOGIC STUDY OF SUBSEQUENT PROPHYLAXIS, STREPTOCOCCAL INFECTIONS, AND CLINICAL SEQUELAE. VI. CLINICAL FEATURES OF STREPTOCOCCAL INFECTIONS AND RHEUMATIC RECURRENCES. (1964) (44)
Editorial: Is decision analysis useful in clinical medicine? (1976) (43)
XLIV. A survey of the research architecture used for publications in general medical journals (1978) (43)
An analysis of diagnostic reasoning. I. The domains and disorders of clinical macrobiology. (1973) (43)
Ordering Patterns and Clinical Impact of Cardiovascular Nuclear Medicine Procedures (1980) (43)
XXIII. The role of randomization in sampling, testing, allocation, and credulous idolatry (Part 2) (1973) (43)
The role of prognostic stratification in preventing the bias permitted by random allocation of treatment. (1976) (42)
Clinical biostatistics. XLI. Hard science, soft data, and the challenges of choosing clinical variables in research. (1977) (42)
Clinical biostatistics. XV. The process of prognostic stratification. I. (1972) (42)
The role of diagnostic inconsistency in changing rates of occurrence for coronary heart disease. (1992) (42)
Rheumatic Fever in Children and Adolescents: A Long-term Epidemiologic Study of Subsequent Prophylaxis, Streptococcal Infections, and Clinical Sequelae: V. Relation of the Rheumatic Fever Recurrence Rate per Streptococcal Infection to Pre-existing Clinical Features of the Patients (1964) (42)
An informal appraisal of the current status of 'medical sociology'. (1981) (41)
Estimating prognosis with the aid of a conversational-mode computer program. (1972) (41)
Invidious comparisons and unmet clinical challenges. (1992) (41)
Incidence, prevalence, and evidence. Scientific problems in epidemiologic statistics for the occurrence of cancer. (1987) (41)
Necropsy evidence of detection bias in the diagnosis of lung cancer. (1986) (40)
What kind of basic science for clinical medicine? (1970) (40)
A methodological appraisal of research on prognosis after transient ischemic attacks. (1991) (40)
The quest for "power": contradictory hypotheses and inflated sample sizes. (1998) (40)
Clinical biostatistics. XIV. The purposes of prognostic stratification. (1972) (39)
Oxygen as a cause of blindness in premature infants: "autopsy" of a decade of errors in clinical epidemiologic research. (1992) (39)
III. The architecture of clinical research (1970) (39)
SCIENTIFIC METHODOLOGY IN CLINICAL MEDICINE. IV. ACQUISITION OF CLINICAL DATA. (1964) (39)
A comparison of three rating scales for measuring subjective phenomena in clinical research. II. Use of experimentally controlled visual stimuli. (2004) (38)
The application of therapeutic-trial principles to improve the design of epidemiologic research: a case-control study suggesting that anticoagulants reduce mortality in patients with myocardial infarction. (1981) (38)
Duration of blood pressure elevation in accurately predicting surgical cure of renovascular hypertension. (1981) (38)
Exclusion bias and the false relationship of reserpine and breast cancer. (1985) (38)
Indexes of contrast and quantitative significance for comparisons of two groups. (1999) (38)
Detection bias in the diagnostic pursuit of lung cancer. (1988) (37)
Is "quality of care" being mislabeled or mismeasured? (2002) (37)
A new clinical prognostic staging system for acute pancreatitis. (1993) (37)
Prognostic significance of valvular involvement in acute rheumatic fever. (1959) (36)
On classifying cancers while treating patients. (1985) (36)
The role of susceptibility bias in epidemiologic research. (1985) (35)
Basic biomedical science and the destruction of the pathophysiologic bridge from bench to bedside. (1999) (35)
An analysis of diagnostic reasoning. II. The strategy of intermediate decisions. (1973) (35)
A new clinical taxonomy for rating change in functional activities of patients with angina pectoris. (1977) (35)
A reappraisal of the United Kingdom epidemic of fatal asthma. Can general mortality data implicate a therapeutic agent? (1987) (34)
A simple electrocardiographic indication of left atrial enlargement. A study of young patients with rheumatic heart disease. (1963) (34)
XXVIII. The biostatistical problems of pharmaceutical surveillance (1974) (34)
XLVIII. Efficacy of different research structures in preventing bias in the analysis of causation (1979) (34)
Quality of data in the medical record. (1970) (34)
XLVII. Scientific standards vs. statistical associations and biologic logic in the analysis of causation (1979) (34)
Clinical effects of recurrent attacks of acute rheumatic fever: a prospective epidemiologic study of 105 episodes. (1967) (33)
Clinical epidemiology. 3. The clinical design of statistics in therapy. (1968) (33)
A comparison of multivariable mathematical methods for predicting survival--I. Introduction, rationale, and general strategy. (1990) (33)
EVALUATION OF INDIVIDUAL COMPLAINTS BEFORE TOTAL HIP REPLACEMENT (1994) (33)
SCIENTIFIC METHODOLOGY IN CLINICAL MEDICINE. I. INTRODUCTION, PRINCIPLES, AND CONCEPTS. (1964) (32)
Prognostic staging system for recurrent, persistent, and second primary cancers of the oral cavity and oropharynx. (1998) (32)
Clinical biostatistics; XXXVII. Demeaned errors, confidence games, nonplussed minuses, inefficient coefficients, and other statistical disruptions of scientific communication (1976) (31)
Prophylaxis of recurrent rheumatic fever. Therapeutic-continuous oral penicillin vs monthly injections. (1968) (31)
An analysis of diagnostic reasoning. 3. The construction of clinical algorithms. (1974) (31)
"Chronic" rheumatic fever. (1962) (30)
xxxv. The persistent clinical failures and fallacies of the UGDP study (1976) (30)
Joseph Goldberger: An Unsung Hero of American Clinical Epidemiology (1994) (30)
The Epidemiology of Cancer Therapy: II. The Clinical Course: Data, Decisions, and Temporal Demarcations (1969) (30)
XVII. Synchronous partition and bivariate evaluation in predictive stratification (1972) (29)
Tempest in a p-pot? (1985) (29)
Rheumatic Fever in Children and Adolescents: A Long-term Epidemiologic Study of Subsequent Prophylaxis, Streptococcal Infections, and Clinical Sequelae: IV. Relation of the Rheumatic Fever Recurrence Rate per Streptococcal Infection to the Titers of Streptococcal Antibodies (1964) (29)
Clinical biostatistics. XVI. The process of prognostic stratification. 2. (1972) (29)
XXX. Biostatistical problems in ‘compliance bias’ (1974) (28)
Tumour staging and classification in lung cancer. Summary of the international symposium (2000) (28)
Para-analysis, faute de mieux, and the perils of riding on a data barge. (1989) (28)
An algebraic analysis of biases due to exclusion, susceptibility, and protopathic prescription in case-control research. (1981) (27)
What is a health care trial? (1975) (27)
Early postpartum discharges. Impact on distress and outpatient problems. (1999) (27)
I. Incidence and Significance ‡ (1961) (27)
Alternative data sources and discrepant results in case-control studies of estrogens and endometrial cancer. (1980) (27)
On central tendency and the meaning of mean for pH values. (1979) (27)
Computer-aided prognosis. II. Development of a prognostic algorithm. (1971) (27)
The epidemiology of cancer therapy. I. Clinical problems of statistical surveys. (1969) (27)
XXIV. The role of randomization in sampling, testing, allocation, and credulous idolatry (conclusion) (1973) (26)
Experimental requirements and scientific principles in case-control studies. (1985) (26)
SCIENTIFIC METHODOLOGY IN CLINICAL MEDICINE. II. CLASSIFICATION OF HUMAN DISEASE BY CLINICAL BEHAVIOR. (1964) (26)
The Blame-X syndrome: problems and lessons in nosology, spectrum, and etiology. (2001) (25)
The value and hazards of standardization in clinical epidemiologic research. (1988) (25)
A new clinical index of growth rate in the staging of breast cancer. (1980) (25)
The Evaluation of Consistency (1987) (24)
Taxonorics. II. Formats and coding systems for data processing. (1970) (24)
Methodologic sources of inconsistent prognoses for post-acute myocardial infarction. (1995) (24)
A review of systems for the personal aspects of patient care. (1988) (24)
Diethylstilbestrol and clear cell vaginal carcinoma. Reappraisal of the epidemiologic evidence. (1986) (24)
Choosing cases and controls: the clinical epidemiology of "clinical investigation". (1988) (24)
RHEUMATIC FEVER IN CHILDREN AND ADOLESCENTS. A LONG-TERM EPIDEMIOLOGIC STUDY OF SUBSEQUENT PROPHYLAXIS, STREPTOCOCCAL INFECTIONS, AND CLINICAL SEQUELAE. I. DESCRIPTION OF THE INVESTIGATIVE TECHNIQUES AND OF THE POPULATION STUDIED. (1964) (24)
Case-control study of oral contraceptive pills and endometrial cancer. (1979) (23)
x. Sources of ‘transition bias’ in cohort statistics (1971) (23)
The use of a formula diet for weight reduction of obese out-patients. (1958) (23)
Estrogens and endometrial cancer. (1979) (22)
Ocular involvement in lymphomatous disease. (1952) (22)
The rebound phenomenon in acute rheumatic fever. I. Incidence and significance. (1961) (22)
Toxic shock and tampons. Evaluation of the epidemiologic evidence. (1982) (22)
XXVII. The derangements of the 'range of normal' (1974) (22)
The diverse effects of histopathology on manifestations and outcome of lung cancer. (1974) (22)
Taxonorics. I. Formulation of criteria. (1970) (22)
A critique of the statistical evidence associating estrogens with endometrial cancer. (1978) (21)
Antecedent therapy versus detection bias as causes of neoplastic multimorbidity. (1999) (21)
Standards, stethoscopes, steroids and statistics. The problem of evaluating treatment in acute rheumatic fever. (1961) (20)
Clinical biostatistics; XXXII. Biologie dependeney, 'hypothesis testing', unilateral probabilities, and other issues in seientifie direetion vs. statistieal duplexity (1975) (20)
The preceding illness of acute rheumatic fever. (1962) (20)
RHEUMATIC FEVER IN CHILDREN AND ADOLESCENTS. A LONG-TERM EPIDEMIOLOGIC STUDY OF SUBSEQUENT PROPHYLAXIS, STREPTOCOCCAL INFECTIONS, AND CLINICAL SEQUELAE. II. MAINTENANCE AND PRESERVATION OF THE POPULATION. (1964) (20)
Twentieth century paradigms that threaten both scientific and humane medicine in the twenty-first century. (1996) (20)
PROPHYLAXIS OF RECURRENT RHEUMATIC FEVER: INEFFECTIVENESS OF INTERMITTENT "THERAPEUTIC" ORAL PENICILLIN. (1965) (20)
Quantitative ambiguities in matched versus unmatched analyses of the 2x2 table for a case-control study. (1987) (19)
Statistical reductionism and clinicians' delinquencies in humanistic research (1999) (19)
The evaluation of sensibility and the role of patient collaboration in clinimetric indexes. (1985) (19)
Prognostic Value of Clinical Variables in Invasive Cervical Cancer (1994) (19)
System, supervision, standards, and the 'epidemic' of negligent medical errors. (1997) (19)
X and iprP: an improved summary for scientific communication. (1987) (19)
XL. Stochastic significance, consistency, apposite data, and some other remedies for the intellectual pollutants of statistical vocabulary (1977) (18)
Association Between Functional Status and Use and Effectiveness of Beta‐Blocker Prophylaxis in Elderly Survivors of Acute Myocardial Infarction (2004) (18)
Diagnostic bias and toxic shock syndrome. (1984) (18)
Presenting manifestations, cigarette smoking, and detection bias in age at diagnosis of lung cancer. (2001) (18)
THE BASIC ELEMENTS OF CLINICAL SCIENCE. (1963) (18)
A controlled psychologic study of Sydenham's chorea. (1962) (18)
ORAL PROPHYLAXIS OF RECURRENT RHEUMATIC FEVER. SULFADIAZINE VS A DOUBLE DAILY DOSE OF PENICILLIN. (1964) (17)
The clinical significance of hyperglobulinemia. I. Diagnostic implications. (1956) (17)
A clinimetric approach to the components of the patient-physician relationship. (1997) (17)
SCIENTIFIC METHODOLOGY IN CLINICAL MEDICINE. 3. THE EVALUATION OF THERAPEUTIC RESPONSE. (1964) (17)
A reappraisal of staging and therapy for patients with cancer of the rectum. II. Patterns of presentation and outcome of treatment. (1975) (17)
XIII. On homogeneity, taxonomy, and nosography (1972) (16)
Post-therapeutic response and therapeutic "style": re-formulating the "placebo effect". (2002) (16)
The Evaluation of Validity (1987) (16)
CONGESTIVE HEART FAILURE AND RHEUMATIC ACTIVITY IN YOUNG PATIENTS WITH RHEUMATIC HEART DISEASE. (1964) (16)
Directionality and scientific inference. (1989) (16)
XVIII. The clofibrate trials: Another dispute about contratrophic therapy (1972) (16)
An analytic critique of existing systems of staging for breast cancer. (1973) (16)
VI. Statistical “malpractice”–and the responsibility of a consultant (1970) (16)
The unheard diastolic murmur in acute rheumatic fever. (1959) (16)
The changing emphasis in clinical research. I. Topics under investigation. An analysis of the submitted abstracts and selected programs at the annual "Atlantic City Meetings" during 1953 through 1965. (1967) (15)
Pretherapeutic morbidity in the prognostic staging of acute leukemia. (1979) (15)
IX. How do we measure “safety and efficacy“? (1971) (15)
XLII. The architecture of cross‐sectional research (Part I) (1978) (15)
LIII. The architecture of observer/method variability and other types of process research (1980) (15)
Classifying clinical severity to help solve problems of stage migration in nonconcurrent comparisons of lung cancer therapy. (1990) (15)
Discontinuation of antistreptococcal prophylaxis. A double-blind study in rheumatic patients free of heart disease. (1966) (15)
Global Indexes and Scales (1987) (15)
XXVI. Medical ethics and the architecture of clinical research (1974) (15)
The Will Rogers phenomenon: improved technologic diagnosis and stage migration as a source of nontherapeutic improvement in cancer prognosis. (1984) (14)
Two centuries of conflict-collaboration between medicine and mathematics. (1996) (14)
Rates of sensitivity reactions to aspirin: Problems in interpreting the data (1986) (14)
Oral Prophylaxis of Recurrent Rheumatic Fever (1965) (14)
Clinical utility of endoscopic retrograde cholangiopancreatography. (1997) (13)
The duration of activity in acute rheumatic fever. (1961) (13)
Radiologic evaluation of heart size in rheumatic heart disease. Studies in young patients. (1963) (13)
Clinical biostatistics. II. Statistics versus science in design of experiments. (1970) (13)
Rigorous new approach to constructing a gold standard for validating new diagnostic criteria, as exemplified by the eosinophilia-myalgia syndrome. (2001) (13)
The stethoscope: a source of diagnostic aid and conceptual errors in rheumatic heart disease. (1960) (13)
RAPID GROWTH RATE IN BREAST CANCER: A CONFOUNDING VARIABLE IN ADJUVANT-CHEMOTHERAPY TRIALS (1982) (13)
IV. Protection against infection insusceptible individuals (1961) (13)
Sore throats, streptococcal infections, and prevention of rheumatic fever. (1962) (13)
The Effectiveness of Panendoscopy on Diagnostic and Therapeutic Decisions about Chronic Abdominal Pain (1980) (13)
Case-control research. Temporal precedence and other problems of the exposure-disease relationship. (1984) (13)
Compassion, computers, and the regulation of clinical technology. (1967) (13)
Histopathologic distinctions in the relationship of estrogens and endometrial cancer. (1981) (12)
In Vivo: The Case for Supramolecular Biology (1967) (12)
Clinical biostatistics. XXII. The role of randomization in sampling, testing, allocation, and credulous idolatry. (1973) (12)
LII. a primer on quantitative indexes of association (1980) (12)
Variance and dissent (1983) (12)
In-vivo and post-mortem gallstones: support for validity of the "epidemiologic necropsy" screening technique. (1991) (12)
Calcium carbonate and constipation: a historical review of medical mythopoeia. (1977) (12)
Physical activities and rheumatic heart disease in asymptomatic patients. (1962) (12)
Mathematical models and scientific reality in occurrence rates for disease. (1989) (12)
The clinical patterns of acute rheumatic fever: a reappraisal. 1962. (1962) (12)
Tumor staging and classification in lung cancer. Summary of the international symposium. Madrid, Spain, 3-4 December 1999. (2000) (12)
IV. The architecture of clinical research (continued) (1970) (11)
A new name—and some other changes of the guard (1970) (11)
VII. The rancid sampie, the tilted target, and the medical poll‐bearer (1971) (11)
Abstruse comparisons: the problems of numerical contrasts of two groups. (1999) (11)
XLVI. What are the criteria for criteria? (1979) (11)
Hepatitis B vaccine (1984) (11)
Advantages and Drawbacks of the Zelen Design for Randomized Clinical Trials (1980) (11)
The impact of symptoms and comorbidity on prognosis in stage IB cervical cancer. (1993) (10)
On choosing the control group in case-control studies. (1983) (10)
The changing emphasis in clinical research. 3. Follow-up report for the years 1965-1969. (1970) (10)
Scientific standards and epidemiologic methods. (1987) (10)
TAXONOMY AND LOGIC IN CLINICAL DATA * (1969) (10)
The Robert Wood Johnson Clinical Scholars Program (1975) (10)
Scientific news and epidemiologic editorials: a reply to the critics. (1990) (10)
Unlearned lessons from clinical trials: A duality of outlooks (1989) (10)
What can clinicians contribute to mutual challenges in medical statistics? (1999) (10)
Scholars, Investigators, and Entrepreneurs: The Metamorphosis of American Medicine (2003) (10)
Physical Examination in Health and Disease (1964) (10)
The pattern of symptoms, pre-treatment interval, and prognosis of acute rheumatic fever. (1962) (10)
Some ethical issues among editors, reviewers and readers. (1986) (9)
Analysis of clinical susceptibility bias in case-control studies. Analysis as illustrated by the menopausal syndrome and the risk of endometrial cancer. (1979) (9)
The Journal of Clinical Epidemiology: same wine, new label for the Journal of Chronic Diseases. (1988) (9)
On blind men, elephants, spectrums, and controversies: lessons from rheumatic fever revisited. (1986) (9)
LVII. A glossary of neologisms in quantitative clinical science (1981) (9)
Clinical and intellectual causes of defective statistics for the prognosis and treatment of lung cancer. (1967) (9)
Graphical display of categorical data. (1993) (9)
L. On choosing a mean and other quantitative indexes to describe the location and dispersion of univariate data (1980) (9)
LVI. The t test and the basic ethos of parametric statistical inference (Conclusion) (1981) (9)
LI. Quantitative significance and statistical indexes for a contrast of two groups (1980) (9)
Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance. (1974) (9)
XLIII. The architecture of cross‐sectional research (conclusion) (1978) (9)
Observer variability in mammography. (1993) (9)
Errors in the diagnosis of acute rheumatic fever. (1960) (9)
Construction, consent, and condemnation in research on peer review. (1991) (9)
Severity of comorbidity, not type of surgery, affects outcome of prostatectomy. (1990) (8)
Response to initial therapy and new onset as predictors of prognosis in patients hospitalized with congestive heart failure. (1992) (8)
Models, methods, and goals. (1989) (8)
Clinical biostatistics; XXXIII. On teaching statistics to medical students (1975) (8)
An analysis of gastric and oesophageal cancers found with 'epidemiological necropsy' during 1953-1982. (1989) (8)
Changes in the diagnostic process during 40 years of clinicopathologic conferences. (1971) (8)
Cigarette smoking and lung cancer: the problems of "detection bias" in epidemiologic rates of disease. (1974) (8)
XLV. The purposes and functions of criteria (1978) (8)
"Rheumatic activity". A clinicopathologic correlation. (1966) (8)
Computer-aided prognosis. I. Organization and coding of data. (1971) (8)
Performance of ergonovine provocative testing for coronary artery spasm. Health and Public Policy Committee, American College of Physicians. (1984) (8)
Clinical biostatistics. 13. On homogeneity, taxonomy, and nosography. (1972) (8)
A18 A simulation study of the number of events per variable recommended in multivariable regression analyses (1993) (8)
More Blood for the Anticoagulant Battle (1975) (8)
Incidence, Prevalence, and Evidence. Scientific Problems in Epidemiologic Statistics for the Occurrence of Cancer (1987) (8)
XXI. A primer of concepts, phrases, and procedures in the statistical analysis of multiple variables (1973) (8)
Experimental reactivation of subsiding rheumatic fever. (1961) (8)
XXXVI. The persistent biometric problems of the UGDP study (1976) (7)
Will clinicians' challenges be solved by another theoretical model? Commentary on Sweeney & Kernick (2002), Clinical evaluation: constructing a new model for post-normal medicine. Journal of Evaluation in Clinical Practice 8, 131-138. (2002) (7)
Rate of disease progression in breast cancer: a clinical estimate of prognosis within nodal and anatomic stages. (1984) (7)
V. The architecture of clinical research (concluded) (1970) (7)
MANIFESTATIONS AND TREATMENT OF CONGESTIVE HEART FAILURE IN YOUNG PATIENTS WITH RHEUMATIC HEART DISEASE. (1964) (7)
The peer-review process--and an acknowledgement of our peerless reviewers. (1989) (7)
Glossary of cardiologic terms related to physical diagnosis and history. II. Heart sounds. (1967) (7)
Epidemiologic and clinical challenges in reviving the necropsy. (1996) (7)
The changing emphasis in clinical research. II. Sites and sources of the investigations. (1967) (7)
Clinical biostatistics. VII. The rancid sample, the tilted target, and the medical poll-bearer. (1971) (7)
Clinical biostatistics. 3. The architecture of clinical research. (1970) (7)
LV. The t test and the basic ethos of parametric statistical inference (part I) (1981) (7)
XIX. Ambiguity and abuse in the twelve different concepts of “Control” (1973) (7)
The bias caused by high values of incidence for p1 in the odds ratio assumption that 1 − p1 − 1 (1986) (7)
III. Prophylaxis of poststreptococcal sequelae and bacterial endocarditis (1961) (7)
Lung cancer staging. A critical evaluation. (1982) (6)
Principles and practice of clinimetrics in epilepsy (1993) (6)
Intravaginal estrogen creams and endometrial cancer: no causal association found. (1979) (6)
Clinical biostatistics. XLV. The purposes and functions of criteria. (1978) (6)
The natural histories of acute rheumatic fever. (1966) (6)
Reprise and lyrics for another chorus. (1991) (6)
A rating system for prompt clinical diagnosis of ischemic stroke. (2000) (6)
Acoustic distinctions in cardiac auscultation with emphasis on cardiophonetics, synecphonesis, the analysis of cadence, and the problems of hydraulic distortion. (1968) (6)
Nomenclature and Functional Classification of Clinimetric Indexes (1987) (6)
Should placebo-controlled trials be abolished? (2004) (6)
Scientific paradigms and ethical problems in epidemiologic research. (1991) (6)
A new method, using radioiron, for determining the iron-binding capacity of human serum. (1953) (5)
An empirical comparison of random numbers acquired by computer-generation and from the rand tables. (1973) (5)
Glossary of cardiologic terms related to physical diagnosis: Part IV. Arterial pulses (1971) (5)
Clinical biostatistics. IV. The architecture of clinical research (continued). (1970) (5)
The Epidemiologic Necropsy-Reply (1987) (5)
Rapid growth rate: a method of identifying node-negative breast cancer patients with a high risk of recurrence. (1983) (5)
Art, Science, and the Doctor‐Patient Relationship (1994) (5)
Clinical Judgment in the Era of Automation (1970) (5)
Meta-analysis and meta-analytic monitoring of clinical trials. (1996) (5)
II. Treatment and Prevention † (1961) (5)
Who checks what in the divided responsibilities of editors and authors? (1988) (5)
The unknown reviewer: an expression of policy and gratitude. (1987) (5)
Effect of restraints on diagnostic approaches to abdominal pain and weight loss. (1986) (5)
CLINIMETRICS AND PSYCHOMETRICS WORK HAND IN HAND. AUTHOR'S REPLY (1999) (5)
Clinical biostatistics. XXX. Biostatistical problems in 'compliance bias'. (1974) (5)
An analysis of the reporting of results in lung cancer drug trials. (1980) (5)
The use of a computer for data management in large-scale long-term cooperative studies. (1973) (5)
Tourniquet test for capillary fragility in diabetes. (1986) (4)
XXXVIII. Computer malpractice (1977) (4)
Factors influencing the in vitro uptake of radiophosphorus by human erythrocytes. (1953) (4)
Clinical biostatistics (1977) (4)
Clinical reasoning and the new "non-" nosology. (1993) (4)
Corticosteroids in stable chronic obstructive pulmonary disease: reappraisal of efficacy. (1987) (4)
Glossary of cardiologic terms related to physical diagnosis and history. (1969) (4)
XXXII. biologic dependency, "hypothesis testing", unilateral probabilities, and other issues in scientific direction vs. statistical duplexity. (1975) (4)
Diagnostic criteria and technology as sources for changing incidences of pulmonary diseases. (1990) (4)
In reply: epidemiologic investigation. (1989) (4)
Directionality in epidemiologic research. (1988) (4)
Evaluating “Conformity” and Marker Tests (2001) (4)
Estrogens and endometrial cancer. (1979) (4)
An effective new prognostic staging system for AIDS. (1988) (4)
Happy anniversary and an impending change of name (1987) (4)
Symptoms as an index of growth rates and prognosis in Hodgkin's disease. (1978) (4)
How good is the statistical evidence against oral hypoglycemic agents? (1979) (4)
Scholars, Investigators, and Entrepreneurs (2003) (3)
A procedure for rapid mental calculation of the fourfold chi-square test. (1972) (3)
Clinical biostatistics. 18. The clofibrate trials: another dispute about contratrophic therapy. (1972) (3)
Does “Health Promotion” Really Promote Health? (2005) (3)
Permutation tests and "statistical significance." 1977. (1993) (3)
The clinical significance of hyperglobulinemia. II. Correlation with liver function tests, serologic tests for syphilis, and bone marrow examinations. (1956) (3)
CHROMOSOMAL DAMAGE AND HAIR DYES (1978) (3)
Letter to the EditorReply from the authors (2001) (3)
The Clinical Epidemiology of Breast and Uterine Cancer (1980) (3)
Black-box mathematics and medical practice. (1993) (3)
Beyond statistics: what is really important in medicine? (1997) (3)
Corticosteroids in stable chronic obstructive pulmonary disease (2007) (3)
Joseph Goldberger: Unsung Hero (1995) (3)
XLIX. The basic data structures used in quantitative indexes (1979) (3)
Oestrogen treatment and endometrial carcinoma. (1977) (3)
Randomized trials vs. historical controls: the scientific plagues of both houses. (1977) (3)
Clinical biostatistics. XXIX. On the biologic content of biometric literature. (1974) (3)
On standards for publication of therapeutic research. (1980) (2)
A box-graph method for illustrating relative-size relationships in a 2 x 2 table. (1988) (2)
Measurement in Medicine: The Interpretation of Numerical Data (1970) (2)
Dr. Feinstein Responds (1990) (2)
Strategies for Improving and Expanding the Application of Health Status Measures in Clinical Settings: General Audience Discussion (1992) (2)
Additional basic approaches in clinical research. (1985) (2)
DETECTION BIAS IN ENDOMETRIAL CANCER (1982) (2)
PROPHYLAXIS OF RHEUMATIC FEVER. (1964) (2)
Computers in medicine: automation vs. improvement of status quo (1969) (2)
Coronary heart disease. The seventh Hahnemann symposium (1963) (2)
Notes on Physical Diagnosis (1964) (2)
Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis (1964) (2)
Quantitative Contrasts: The Magnitude of Distinctions (2001) (2)
An expression of gratitude to the journal's reviewers (1991) (2)
STANDARDS, STETHOSCOPES, STEROIDS AND STATISTICS (1961) (2)
Protection against infection in susceptible individuals. (1961) (2)
XV. The process of prognostic stratification (Part I) (1972) (2)
Basic Principles in the Structure of Clinimetric Indexes (1987) (2)
Case-control studies of estrogens and endometrial cancer. (1979) (2)
Glossary of cardiologic terms related to physical diagnosis and history. 3. Anterior chest movements. The ventricles, the atria, and the great vessels. (1969) (2)
Theoretical Perspectives in Causality Assessment (1984) (2)
Farewell and hail (1995) (2)
2 – Biases introduced by confounding and imperfect retrospective and prospective exposure assessments (1997) (2)
Clinical biostatistics. 23. The role of randomization in sampling, testing, allocation, and credulous idolatry. 2. (1973) (2)
Reappraisal of the United Kingdom Epidemic of Fatal Asthma-Reply (1987) (2)
Choice of Component Variables (1987) (2)
Secular trends in coronary atherosclerosis. (1997) (2)
On publishing accounts of methods (1983) (2)
Zeta and delta: critical descriptive boundaries in statistical analysis. (1998) (2)
Parametric Sampling: Z and t Tests (2001) (1)
Current status of prophylaxis against rheumatic fever. (1960) (1)
The state of the Journal. (1997) (1)
A clinical method for estimating the rate of growth of a cancer. (1969) (1)
The BCG Controversy-Reply (1983) (1)
Multiple Stochastic Testing (2001) (1)
Neel Distinguished Research Lecturer: Alvan R Feinstein, MD (2001) (1)
Non-Parametric Rank Tests (2001) (1)
Single weekly doses of oral sulfamethoxypyridazine in preventing recurrences of rheumatic fever (1966) (1)
Hail and farewell (1982) (1)
The changing system of cancer staging. (1980) (1)
Bedside Diagnostic Examination: A Comprehensive Pocket Textbook (1965) (1)
PROBLEMS IN DEFINING QUALITY OF LIFE (1997) (1)
The crisis in clinical research. Essay review. (1995) (1)
Clinical biostatistics. XLIII. The architecture of cross-sectional reserach (conclusion). (1978) (1)
Stratifications, Matchings, and “Adjustments” (2001) (1)
Time-related factors in cancer epidemiology (1987) (1)
Scientific defects in the staging of cancer. (1971) (1)
Reappraisal of the Epidemiologic Evidence (1986) (1)
Problems, pitfalls, and opportunities in long-term randomized trials. (1989) (1)
Savill's System of Clinical Medicine (1951) (1)
Tonsils and rheumatic fever. (1970) (1)
Clinical biostatistics (1970) (1)
XXII. The role of randomization in sampling, testing, allocation, and credulous idolatry (Part 1) (1973) (1)
Penicillin prophylaxis of recurrent rheumatic fever: A therapeutic-continuous oral regimen vs. monthly injections (1967) (1)
Organization of the Output Scale (1987) (1)
Response Value for the money (1992) (1)
An acknowledgement and appreciation of help (1985) (1)
Prophylaxis of poststreptococcal sequelae and bacterial endocarditis. (1961) (1)
The Clinical Significance of Hyperglobulinemia. I. Diagnostic Implications (1956) (1)
Classification of epidemiologic research. (1988) (1)
Two new indexes for assessing clinical improvement in angina pectoris. (1975) (1)
Relationship between nonphenacetin-combined analgesics and nephropathy. Author's reply (2001) (1)
Community surveillance bias and the estrogen-endometrial cancer dispute. (1979) (1)
Editorial: The Robert Wood Johnson Clinical Scholars Program. (1975) (1)
Prophylactic and remedial therapy for the intellectual ailments of 'biostatistics'. (1983) (1)
Inner Zones and Spreads (2001) (1)
Kappa Test of Concordance (Update) (2004) (0)
Clinimetrics and Psychometrics Work Hand in Hand (1999) (0)
An expanded editorial board (1993) (0)
20. Cardiac effects of rheumatic fever recurrences: A prospective study of 105 episodes (1965) (0)
Indexes of Inner Location (2001) (0)
Interpretations and Displays for Two-Group Contrasts (2001) (0)
Medical consultations to noninternists impact on diagnosis and therapy (1981) (0)
TRUE CONFESSIONS. AUTHORS' REPLY (1993) (0)
CARDIAC NOISES. (1963) (0)
More history of medical statistics. (1998) (0)
Risk Factors for Amputation in Diabetics (1993) (0)
Response : Epidemiologic Investigation (1989) (0)
Coffee and Cancer of the Pancreas-Reply (1982) (0)
Leopold's Principles and Methods of Physical Diagnosis (1965) (0)
QUANTIFICATION AND THE QUEST FOR MEDICAL CERTAINTY. AUTHOR'S REPLY (1997) (0)
Cybernetic Medicine (1966) (0)
[Natural history and therapeutic concepts of acute rheumatic fever]. (1969) (0)
Editorial: More blood for the anticoagulant battle. (1975) (0)
Confidence Intervals and Stability: Means and Medians (2001) (0)
NATURAL HISTORY AND TREATMENT OF RHEUMATIC FEVER. (1964) (0)
Clinical biostatistics. XXXVIII. Computer malpractice. (1977) (0)
Pharmacoepidemiology: a formal welcome (1991) (0)
Avoiding conflicts of interest in drug research. (1979) (0)
Therapies for Benign Prostatic Hyperplasia-Reply (1992) (0)
Annual Meeting and OTO EXPO Exhibits (2001) (0)
Testing for “Equivalence” (2001) (0)
Analysis of Variance (2001) (0)
A Pragmatic Taxonomy for Classifying Clinimetric Indexes (1987) (0)
Reflections on reaching a quadricentennial. (1999) (0)
Glossary of cardiologic terms related to physical diagnosis and history. 3. Anterior chest movements: the ventricles, the atria, and the great vessels. (1969) (0)
Problems and challenges in randomized trials: a commentary. (1980) (0)
Wednesday, September 12, 2001 (2001) (0)
In Reply: Treatment of Rheumatic Fever (1962) (0)
On numerators, denominators, and virgules. (1975) (0)
Tempest in a F-Pot? (2005) (0)
THERAPIES FOR BENIGN PROSTATIC HYPERPLASIA. AUTHOR'S REPLY (1992) (0)
The etymology and pathogenesis of "wonk". (1995) (0)
Training and purpose of the clinical scientist. (1971) (0)
Review of the first year. (1983) (0)
Rational diagnosis and treatment: By Henrik R. Wulff. 182 pp., 25 illustrations, 18 tables, $12.50. J. B. Lippincott Company, Philadelphia (1979) (0)
Lidocaine Prophylaxis and Myocardial Infarction-Reply (1982) (0)
Advantages and drawbacks of the Zelen design for randomized clinical trials. (1980) (0)
Radiologists' Interpretations: The Problem of Context Bias-Reply (1997) (0)
Letter to the editorResponse (1991) (0)
Tumor registries and the clinical biology of chronic disease. (1967) (0)
Computer Diagnosis and Diagnostic Methods (1973) (0)
The Goals of Statistical Methods (1987) (0)
Chi-Square Test and Evaluation of Two Proportions (2001) (0)
Testing Stochastic Hypotheses (2001) (0)
Survival and Longitudinal Analysis (2001) (0)
LEUKOCYTE ESTERASE TESTS DETECT PYURIA, NOT BACTERIURIA. AUTHOR'S REPLY (1993) (0)
Letter to the editorThe reply (1987) (0)
Book Review:American Medicine and Statistical Thinking, 1800-1860. James H. Cassedy (1985) (0)
Annual Meeting and OTO EXPO Exhibits∗ (2001) (0)
Rheumatic Fever: Natural History and Treatment (1965) (0)
Experimental trials and case-control studies in the analysis of causality. (1982) (0)
Startling statements. (1992) (0)
Principles of Associations (2001) (0)
ANTICOAGULANTS AND MYOCARDIAL INFARCTION (1958) (0)
Impact on Interracial Comparisons of Inappropriate Criteria for Cardiac Enlargement in Blacks (2005) (0)
Why are clinical statistics so misleading? (1972) (0)
Central Index of a Group (2001) (0)
The problem of treatment in obesity. (1961) (0)
Recurrence of rheumatic fever. (1985) (0)
The Quality of Quality-of-Life Measurements-Reply (1995) (0)
Permutation Rearrangements: Fisher Exact and Pitman-Welch Tests (2001) (0)
Indexes Requiring Active Collaboration by Patients (1987) (0)
Formation, Expression, and Coding of Data (2001) (0)
Book ReviewControversy in Internal Medicine. II. (1974) (0)
Clinical Judgment (1994) (0)
Case-control studies (1989) (0)
Response from the Editors (1989) (0)
Therapies for benign prostatic hyperplasia. (1993) (0)
Clinicians May Be Scholars (1970) (0)
Group diversity as a threat to individual economy in ordering diagnostic procedures. (1984) (0)
Indexes of Categorical Association (2001) (0)
The fragility of an altered proportion: a simple method for explaining standard errors. (1987) (0)
A New Look at Rheumatic Fever (1968) (0)
Correction: Apology for Hypercalcinuria (1975) (0)
Outspoken Criticism Enhances Medical Education—Reply (1998) (0)
Millenarian visions and medical realities William B Schwartz Life Without Disease (1998) (0)
Alternative Hypotheses and Statistical “Power” (2001) (0)
Review of Clinical Epidemiology (1986) (0)
The illness preceding acute rheumatic fever. (1962) (0)
Communication and Display of Univariate Data (2001) (0)
Glossary of Cardiologic Terms Related to Physical Diagnosis Part IV. Arterial Pulses Committee on Standardized Terminology, American College of Cardiology and American Heart Association (1971) (0)
Panel discussion. I: Cost effectiveness of drug development and health economics. (1989) (0)
Multivariable Analysis (1996) (0)
Advances in rheumatic fever, 1940-1961. Epidemiological and clinical studies of patients during the first five decades of life. (1963) (0)
35.“Rheumatic activity”: A clinicopathologic correlation (1965) (0)
259 DEVELOPMENT AND TESTING OF AN ALGORITHM FOR RELIABLE CLINICAL IDENTIFICATION OF ADVERSE DRUG REACTIONS (1978) (0)
The bias caused by high values of incidence for p1 in the odds ratio assumption that 1-p1 approximately equal to 1. (1986) (0)
Alternative Strategies to Randomized Clinical Trials-Reply (1982) (0)
Confidence Intervals and Stability: Binary Proportions (2001) (0)
A move from montreal to potsdam (1993) (0)
Rational diagnosis and treatment (1979) (0)
Clinical Examination: A Textbook of Physical Diagnosis (1965) (0)
To Have Been or Not to Have Been (1965) (0)
Probabilities and Standardized Indexes (2001) (0)
Controversy in Internal Medicine (1966) (0)
Rates of sensitivitv reactions to aspirin: I Problems in interbreting the data (1986) (0)
The Theory and Practice of Auscultation (1964) (0)
Non-Targeted Analyses (2001) (0)
Happy birthday, Robert Maxwell and Pergamon Press! (1988) (0)
Host factors in the susceptibility of rheumatic patients to streptococcal infections. (1975) (0)
Summary statistics and treatment decision (1993) (0)
The patient, the physician, and the regulator. (1979) (0)
Recent Developments in Gravitation (1992) (0)
An evaluation of the clinical efficacy of panendoscopy in chronic abdominal pain (1978) (0)
Design and Evaluation of Field Trials (1987) (0)
The Goals of Psychosocial Methods (1987) (0)
State of the Art (2006) (0)
Medalled models and muddled mettle the intellectual crisis in clinical science (1986) (0)
Formula diets and weight reduction. (1960) (0)
Estrogen use and endometrial cancer. (1979) (0)
Special Arrangements for Rates and Proportions (2001) (0)
Smoking and cancer morphology. (1970) (0)
Classics in medicine (1993) (0)
Re: "Do pressurized bronchodilator aerosols cause death among asthmatics?". (1988) (0)
The 'Chagrin Factor' in Obstetrics-Reply (1986) (0)
The Impact of Bias in the Tri-State Toxic-Shock Syndrome Study-Reply (1985) (0)
More lung cancer but better survival for the year 2000 (1987) (0)

This paper list is powered by the following services:

Other Resources About Alvan Feinstein

en.wikipedia.org

What Schools Are Affiliated With Alvan Feinstein?

Alvan Feinstein is affiliated with the following schools:

Alvan Feinstein's Academic­Influence.com Rankings

Alvan Feinstein's Degrees

Why Is Alvan Feinstein Influential?

Alvan Feinstein's Published Works

Published Works

Other Resources About Alvan Feinstein

What Schools Are Affiliated With Alvan Feinstein?

Alvan Feinstein's AcademicInfluence.com Rankings